228 related articles for article (PubMed ID: 35641191)
1. Decoding the antifungal resistance mechanisms in biofilms of emerging, ubiquitous and multidrug-resistant species belonging to the Scedosporium/Lomentospora genera.
Mello TP; Oliveira SSC; Branquinha MH; Santos ALS
Med Mycol; 2022 Jun; 60(6):. PubMed ID: 35641191
[TBL] [Abstract][Full Text] [Related]
2. Impact of biofilm formation and azoles' susceptibility in Scedosporium/Lomentospora species using an in vitro model that mimics the cystic fibrosis patients' airway environment.
Mello TP; Lackner M; Branquinha MH; Santos ALS
J Cyst Fibros; 2021 Mar; 20(2):303-309. PubMed ID: 33334714
[TBL] [Abstract][Full Text] [Related]
3. Cell dispersion during biofilm formation by
Mello TP; Barcellos IC; Branquinha MH; Santos ALS
Curr Res Microb Sci; 2023; 4():100191. PubMed ID: 37229517
[TBL] [Abstract][Full Text] [Related]
4. Active Cu(II), Mn(II) and Ag(I) 1,10-phenanthroline/1,10-phenanthroline-5,6-dione/dicarboxylate chelates: effects on
Mello TP; Aor AC; Barcellos IC; Pereira MM; McCann M; Devereux M; Branquinha MH; Santos AL
Future Microbiol; 2023 Nov; 18():1049-1059. PubMed ID: 37284767
[TBL] [Abstract][Full Text] [Related]
5.
Furnica DT; Dittmer S; Scharmann U; Meis JF; Steinmann J; Rath PM; Kirchhoff L
Microbiol Spectr; 2023 Jun; 11(3):e0513022. PubMed ID: 37017567
[TBL] [Abstract][Full Text] [Related]
6. Pandemic Response Box® library as a source of antifungal drugs against Scedosporium and Lomentospora species.
Rollin-Pinheiro R; Xisto MIDDS; de Castro-Almeida Y; Rochetti VP; Borba-Santos LP; Fontes YDS; Ferreira-Pereira A; Rozental S; Barreto-Bergter E
PLoS One; 2023; 18(2):e0280964. PubMed ID: 36735743
[TBL] [Abstract][Full Text] [Related]
7. Conidial germination in Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans: influence of growth conditions and antifungal susceptibility profiles.
Mello TP; Aor AC; Oliveira SS; Branquinha MH; Santos AL
Mem Inst Oswaldo Cruz; 2016 Jun; 0(7):0. PubMed ID: 27355215
[TBL] [Abstract][Full Text] [Related]
8. Surface properties, adhesion and biofilm formation on different surfaces by
Mello TP; Oliveira SSC; Frasés S; Branquinha MH; Santos ALS
Biofouling; 2018 Aug; 34(7):800-814. PubMed ID: 30354689
[TBL] [Abstract][Full Text] [Related]
9. Biofilms formed by
Mello TP; Branquinha MH; Santos ALS
Biofouling; 2020 Mar; 36(3):308-318. PubMed ID: 32401558
[TBL] [Abstract][Full Text] [Related]
10. Assessment of biofilm formation by Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans.
Mello TP; Aor AC; Gonçalves DS; Seabra SH; Branquinha MH; Santos AL
Biofouling; 2016 Aug; 32(7):737-49. PubMed ID: 27309801
[TBL] [Abstract][Full Text] [Related]
11.
Georgacopoulos O; Nunnally N; Law D; Birch M; Berkow EL; Lockhart SR
Microbiol Spectr; 2023 Feb; 11(1):e0278922. PubMed ID: 36629417
[No Abstract] [Full Text] [Related]
12. Clinical manifestations and susceptibility of Scedosporium/Lomentospora infections at a tertiary medical centre in Taiwan from 2014 to 2021: A retrospective cohort study.
Lao CK; Ou JH; Fan YC; Wu TS; Sun PL
Mycoses; 2023 Oct; 66(10):923-935. PubMed ID: 37449538
[TBL] [Abstract][Full Text] [Related]
13. Activity of Amphotericin B Formulations and Voriconazole, Alone or in Combination, against Biofilms of
Vikelouda K; Simitsopoulou M; Skoura L; Antachopoulos C; Roilides E
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0063821. PubMed ID: 34370583
[No Abstract] [Full Text] [Related]
14. Antibiofilm activity of antifungal drugs, including the novel drug olorofim, against Lomentospora prolificans.
Kirchhoff L; Dittmer S; Weisner AK; Buer J; Rath PM; Steinmann J
J Antimicrob Chemother; 2020 Aug; 75(8):2133-2140. PubMed ID: 32386411
[TBL] [Abstract][Full Text] [Related]
15. Miltefosine Against
Rollin-Pinheiro R; Almeida YC; Rochetti VP; Xisto MIDDS; Borba-Santos LP; Rozental S; Barreto-Bergter E
Front Cell Infect Microbiol; 2021; 11():698662. PubMed ID: 34368017
[No Abstract] [Full Text] [Related]
16. Insights into the interaction of Scedosporium apiospermum, Scedosporium aurantiacum, Scedosporium minutisporum, and Lomentospora prolificans with lung epithelial cells.
de Mello TP; Aor AC; Branquinha MH; Dos Santos ALS
Braz J Microbiol; 2020 Jun; 51(2):427-436. PubMed ID: 31736016
[TBL] [Abstract][Full Text] [Related]
17. Repurposing of auranofin and honokiol as antifungals against
Yaakoub H; Staerck C; Mina S; Godon C; Fleury M; Bouchara JP; Calenda A
Virulence; 2021 Dec; 12(1):1076-1090. PubMed ID: 33825667
[TBL] [Abstract][Full Text] [Related]
18. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
Wiederhold NP; Law D; Birch M
J Antimicrob Chemother; 2017 Jul; 72(7):1977-1980. PubMed ID: 28333310
[TBL] [Abstract][Full Text] [Related]
19. Antifungal Susceptibility Profiles and Drug Resistance Mechanisms of Clinical Lomentospora prolificans Isolates.
Wu Y; Grossman N; Totten M; Memon W; Fitzgerald A; Ying C; Zhang SX
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816726
[No Abstract] [Full Text] [Related]
20. In vitro activity of olorofim (F901318) against fungi of the genus, Scedosporium and Rasamsonia as well as against Lomentospora prolificans, Exophiala dermatitidis and azole-resistant Aspergillus fumigatus.
Kirchhoff L; Dittmer S; Buer J; Rath PM; Steinmann J
Int J Antimicrob Agents; 2020 Sep; 56(3):106105. PubMed ID: 32721601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]